Cargando…
Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis
Liver fibrosis represents a significant health hazard with a high morbidity rate and an increased risk of liver cancer. Targeting overactivated Fibroblast growth factor receptor 2 (FGFR2) is a promising strategy to counteract collagen accumulation during liver fibrosis. However, there is a shortage...
Autores principales: | Meng, Qilin, Luo, Lin, Lei, Minghua, Chen, Zhiqi, Sun, Yuanmeng, Chen, Xue, Zhai, Zhaodong, Zhang, Yibo, Cao, Jieqiong, Su, Zijian, Li, Fu, Li, Jingsheng, Hong, An, Chen, Xiaojia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145669/ https://www.ncbi.nlm.nih.gov/pubmed/37111305 http://dx.doi.org/10.3390/ph16040548 |
Ejemplares similares
-
Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
por: Su, Zijian, et al.
Publicado: (2023) -
Development and Characterization of a Novel Peptide—Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors
por: Wang, Yayu, et al.
Publicado: (2021) -
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
por: Yang, Yiqi, et al.
Publicado: (2023) -
Beneficial Effects of Cynaroside on Cisplatin-Induced Kidney Injury In Vitro and In Vivo
por: Nho, Jong-Hyun, et al.
Publicado: (2018) -
A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2
por: Zhang, Yibo, et al.
Publicado: (2020)